Skip to main content
. 2019 Apr 30;35(2):72–82. doi: 10.3393/ac.2019.04.22

Fig. 2.

Fig. 2.

Survival analysis in entire patients. Local recurrence-free survival (LRFS) (A) and Distant metastasis-free survival (DFS) (B) between positive ymrCRM group and negative ymrCRM group. LRFS (C) and DFS (D) between positive ymrEMVI group and negative ymrEMVI group. ymrCRM, circumferential resection margin evaluated after preoperative chemoradiotherapy (pCRT); ymrEMVI, extramural venous invasion evaluated after pCRT; F/U, follow-up.